Article
Cost-Effectiveness Model for Evaluating New Diagnostic Tests in the Evaluation of Patients With Inflammatory Arthritis at Risk of Having Rheumatoid Arthritis.
Arthritis care & research - 1 Jul 2016
Luime Jolanda J, Buisman Leander R, Oppe Mark, Hazes Johanna M W, Rutten-van Mölken Maureen P M H
Abstract excerpt
OBJECTIVE: New opportunities have emerged for early diagnosis with the arrival of new technologies that assess the impact of genomics, proteomics, metabolomics, and cytomics on rheumatoid arthritis (RA) risk. This early health technology assessment study assesses the short-term cost effectiveness of 4 add-on diagnostic tests in early inflammatory arthritis patients at risk of RA. METHODS: We modeled 4 diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
